Patents Assigned to Japan Bio Science Laboratory Co., Ltd.
-
Patent number: 8603552Abstract: A method for producing a food product containing nattokinase but containing little or none vitamin K2, comprising treating a Bacillus natto culture or culture supernatant with at least one coagulant selected from the group consisting of an inorganic coagulant and a cationic polymer coagulant (excluding chitosan). As the inorganic coagulant, calcium chloride or poly aluminum chloride is preferable, and their mixtures with a phosphorus coagulant are also preferably used. As the cationic polymer coagulant, cationic polysaccharides, hexamethylenediamine/ephichlorohydrin polycondensates or dimethylamine/epichlorohydrin polycondensates are preferably used, and their mixtures with a polyacrylate are also preferably used.Type: GrantFiled: December 8, 2005Date of Patent: December 10, 2013Assignees: Japan Bio Science Laboratory Co., Ltd., Amano Enzyme IncInventors: Shinsaku Takaoka, Masaharu Yoshida
-
Patent number: 8114642Abstract: A method for producing vitamin K2 comprising: culturing Bacillus natto in a liquid medium to obtain a Bacillus natto culture or culture supernatant thereof, wherein the culture or culture supernatant contains vitamin K2; treating the culture or culture supernatant with at least one coagulant selected from the group consisting of an inorganic coagulant and a cationic polymer coagulant, with the proviso that the coagulant excludes chitosan, so as to obtain a treated coagulant to which vitamin K2 is absorbed or aggregated; separating the treated coagulant from the treated culture or culture supernatant, and obtaining an oily product that contains vitamin K2 from the separated coagulant.Type: GrantFiled: June 28, 2007Date of Patent: February 14, 2012Assignees: Japan Bio Science Laboratory Co., Ltd., Daiwa Kasei K. K.Inventors: Shinsaku Takaoka, Masaharu Yoshida
-
Publication number: 20070254347Abstract: A method for producing vitamin K2 comprising: culturing Bacillus natto in a liquid medium to obtain a Bacillus natto culture or culture supernatant thereof, wherein the culture or culture supernatant contains vitamin K2; treating the culture or culture supernatant with at least one coagulant selected from the group consisting of an inorganic coagulant and a cationic polymer coagulant, with the proviso that the coagulant excludes chitosan, so as to obtain a treated coagulant to which vitamin K2 is absorbed or aggregated; separating the treated coagulant from the treated culture or culture supernatant, and obtaining an oily product that contains vitamin K2 from the separated coagulant.Type: ApplicationFiled: June 28, 2007Publication date: November 1, 2007Applicants: Japan Bio Science Laboratory Co, Ltd., DAIWA KASEI K.K.Inventors: Shinsaku Takaoka, Masaharu Yoshida
-
Publication number: 20060141095Abstract: The present invention provides a method for producing a food product containing nattokinase but containing little or none vitamin K2, comprising treating a Bacillus natto culture or culture supernatant with at least one coagulant selected from the group consisting of an inorganic coagulant and a cationic polymer coagulant (excluding chitosan). As the inorganic coagulant, calcium chloride or poly aluminum chloride is preferable, and their mixtures with a phosphorus coagulant are also preferably used. As the cationic polymer coagulant, cationic polysaccharides, hexamethylenediamine/epichlorohydrin polycondensates or dimethylamine/epichlorohydrin polycondensates are preferably used, and their mixtures with a polyacrylate are also preferably used.Type: ApplicationFiled: December 8, 2005Publication date: June 29, 2006Applicants: Japan Bio Science Laboratory Co., Ltd., Daiwa Kasei K.K.Inventors: Shinsaku Takaoka, Masaharu Yoshida
-
Patent number: 7014851Abstract: An object of the present invention is to provide a platelet aggregation inhibitor without side effects and a supplement food effective for inhibiting platelet aggregation. The platelet aggregation inhibitor has nattokinase as an active ingredient and has Bacillus natto culture extract, containing a high proportion of nattokinase containing 1 ?g/g or less of vitamin K2 on a dry weight basis, as an active ingredient. The supplement food effective for inhibiting platelet aggregation has nattokinase as an active ingredient and has Bacillus natto culture extract, containing a high proportion of nattokinase containing 1 ?g/g or less of vitamin K2 on a dry weight basis, as an active ingredient.Type: GrantFiled: September 2, 2004Date of Patent: March 21, 2006Assignees: V-Tec Co., Ltd., Japan Bio Science Laboratory Co., Ltd.Inventors: Hiroyoshi Moriyama, Shinsaku Takaoka
-
Patent number: 6730504Abstract: A Bacillus natto culture is treated with chitosan, and then filtered, concentrated, and dried. According to this method, a Bacillus natto culture extract containing nattokinase and 1 &mgr;g or less of vitamin K2/g dry weight is obtained.Type: GrantFiled: January 30, 2002Date of Patent: May 4, 2004Assignee: Japan Bio Science Laboratory Co., Ltd.Inventor: Shinsaku Takaoka